NASDAQ:COAG | Cash Flow Statement | Hemab Therapeutics Holdings, Inc.

Complete source-backed cash-flow history.

Available history
2025-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$24.15M
2026-03-31-$22.69M$73,000.00-$21.58M$112,000.00-$15.85M-$460,000.00
2025-06-30-$12.21M
2025-03-31-$15.31M$75,000.00-$13.03M$16,000.00-$5.99M-$29,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow